Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $229.23 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $184.13 | 9 | $0 (2024) |
| PFIZER INC. | $23.04 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $22.06 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $184.13 | 9 | GlaxoSmithKline, LLC. ($184.13) |
| 2023 | $45.10 | 2 | PFIZER INC. ($23.04) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Cardiovascular | ||||||
| 07/21/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 89 | 89 | $100,084 | $13,843 |
| 2022 | 4 | 61 | 61 | $33,937 | $5,704 |
| 2021 | 1 | 12 | 12 | $14,532 | $2,444 |
| 2020 | 1 | 11 | 11 | $13,321 | $1,882 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 70 | 70 | $84,770 | $11,678 | 13.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 19 | 19 | $15,314 | $2,165 | 14.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 19 | 19 | $23,009 | $3,578 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $7,605 | $1,178 | 15.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 17 | 17 | $2,567 | $855.79 | 33.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 12 | 12 | $756.00 | $92.12 | 12.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 12 | 12 | $14,532 | $2,444 | 16.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 11 | 11 | $13,321 | $1,882 | 14.1% |
About Jagruti Patel
Jagruti Patel is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124158423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jagruti Patel has received a total of $229.23 in payments from pharmaceutical and medical device companies, with $184.13 received in 2024. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($229.23).
As a Medicare-enrolled provider, Patel has provided services to 173 Medicare beneficiaries, totaling 173 services with total Medicare billing of $23,874. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Manhasset, NY
- Active Since 03/06/2007
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1124158423
Products in Payments
- AREXVY (Drug) $162.32
- VYNDAQEL (Drug) $23.04
- CAMZYOS (Drug) $22.06
- TRELEGY ELLIPTA (Drug) $21.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Manhasset
Christopher Raio, Md, MD
Emergency Medicine — Payments: $187,256
Joshua Levine, Md, MD
Emergency Medicine — Payments: $13,958
Laura Patruno, Pa, PA
Emergency Medicine — Payments: $5,785
Jason Zemmel D'amore, Md, MD
Emergency Medicine — Payments: $4,719
Dr. Tadeusz Korszun, Md, MD
Emergency Medicine — Payments: $2,243
David Silver, Md, MD
Emergency Medicine — Payments: $1,153